Andreas Selberherr
Medical University of Vienna
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andreas Selberherr.
Clinical Endocrinology | 2016
Philipp Riss; Michael Kammer; Andreas Selberherr; Christoph Bichler; Reto Kaderli; Christian Scheuba; Bruno Niederle
The effects of thiazide medication in patients with primary hyperparathyroidism (PHPT) have so far not been elucidated. The aim of this study was to analyse the extent to which the administration of thiazides may influence biochemical parameters and therefore the diagnosis of PHPT in a large cohort of patients.
Clinical Endocrinology | 2018
Reto Kaderli; Philipp Riss; Angelika Geroldinger; Andreas Selberherr; Christian Scheuba; Bruno Niederle
Little is known about the natural changes in parathyroid function after successful parathyroid surgery for primary hyperparathyroidism. The association of intact parathyroid hormone (iPTH) and calcium (Ca) with “temporary hypoparathyroidism” and “hungry bone syndrome” (HBS) was evaluated.
Visceral medicine | 2017
Andreas Selberherr; Martin B. Niederle; Bruno Niederle
Although the majority of neuroendocrine tumors of the small intestine (siNETs) classified as low-grade G1 or G2 show slow local growth, they are frequently diagnosed at an advanced stage of metastatic disease. The surgical treatment is curative in stages I-III or palliative in stage IV in an attempt to avoid local complications of bowel obstruction and ischemia of the small bowel by unremoved lymph node metastases. Individualized surgical procedures performed by experienced surgeons considering tumor multifocality and the primary extent of lymph node metastases along the mesenteric vessels are recommended to remove as much tumor volume as possible, while avoiding major complications intraoperatively and small bowel syndrome postoperatively.
Clinical Endocrinology | 2017
Reto Kaderli; Philipp Riss; Angelika Geroldinger; Andreas Selberherr; Christian Scheuba; Bruno Niederle
Normal or elevated 24‐hour urinary calcium (Ca) excretion is a diagnostic marker in primary hyperparathyroidism (PHPT). It is used to distinguish familial hypocalciuric hypercalcaemia (FHH) from PHPT by calculating the Ca/creatinine clearance ratio (CCCR). The variance of CCCR in patients with PHPT is considerable. The aim of this study was to analyse the parameters affecting CCCR in patients with PHPT.
Surgery | 2015
Andreas Selberherr; Christian Scheuba; Philipp Riss; Bruno Niederle
Annals of Surgical Oncology | 2015
Philipp Riss; Michael Kammer; Andreas Selberherr; Christian Scheuba; Bruno Niederle
Langenbeck's Archives of Surgery | 2017
Andreas Selberherr; Marcus Hörmann; Gerhard Prager; Philipp Riss; Christian Scheuba; Bruno Niederle
Annals of Surgical Oncology | 2016
Andreas Selberherr; Philipp Riss; Christian Scheuba; Bruno Niederle
European Journal of Endocrinology | 2018
Reto Kaderli; Philipp Riss; Daniela Dunkler; Peter Pietschmann; Andreas Selberherr; Christian Scheuba; Bruno Niederle
Trials | 2018
Lindsay Brammen; Philipp Riss; Julius Lukas; Alois Gessl; Daniela Dunkler; Shuren Li; Asha Leisser; Sandra Rezar-Dreindl; Katharina Eibenberger; Andreas Selberherr; Christian Scheuba; Andrea Papp